08:05 AM EDT, 10/08/2024 (MT Newswires) -- Opthea ( OPT ) said Tuesday it has appointed Parisa Zamiri as its chief medical officer, effective Oct. 7, and Tom Reilly as its chief financial officer, effective Oct. 28.

Zamiri most recently served as Complement Therapeutics' medical chief while Reilly was previously the CFO of Amarin (AMRN).

The company said it is continuing to prepare for the phase 3 topline data readouts of its lead product candidate sozinibercept, with readouts from its COAST study anticipated in early Q2 2025 and from its ShORe trial in mid-2025.